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Abstract
Chronic inflammation of the lung, as a consequence of persistent bacterial infections by several opportunistic pathogens
represents the main cause of mortality and morbidity in cystic fibrosis (CF) patients. Mechanisms leading to increased
susceptibility to bacterial infections in CF are not completely known, although the involvement of cystic fibrosis
transmembrane conductance regulator (CFTR) in microbicidal functions of macrophages is emerging. Tissue macrophages
differentiate in situ from infiltrating monocytes, additionally, mature macrophages from different tissues, although having a
number of common activities, exhibit variation in some molecular and cellular functions. In order to highlight possible
intrinsic macrophage defects due to CFTR dysfunction, we have focused our attention on in vitro differentiated
macrophages from human peripheral blood monocytes. Here we report on the contribution of CFTR in the bactericidal
activity against Pseudomonas aeruginosa of monocyte derived human macrophages. At first, by real time PCR,
immunofluorescence and patch clamp recordings we demonstrated that CFTR is expressed and is mainly localized to
surface plasma membranes of human monocyte derived macrophages (MDM) where it acts as a cAMP-dependent chloride
channel. Next, we evaluated the bactericidal activity of P. aeruginosa infected macrophages from healthy donors and CF
patients by antibiotic protection assays. Our results demonstrate that control and CF macrophages do not differ in the
phagocytic activity when infected with P. aeruginosa. Rather, although a reduction of intracellular live bacteria was detected
in both non-CF and CF cells, the percentage of surviving bacteria was significantly higher in CF cells. These findings further
support the role of CFTR in the fundamental functions of innate immune cells including eradication of bacterial infections
by macrophages.
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Introduction
Cystic fibrosis is the most common genetic disorder affecting the
Caucasian population. The disease is caused by mutations of the
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
which encodes a c-AMP dependent chloride channel [1,2].
Defective chloride secretion due to dysfunctions of CFTR results
in the dehydratation of airway liquid leading to depletion of the
periciliary layer and production of highly viscoelastic mucus which
significantly impact mucociliary clearance and expectoration [3].
This combination of factors prevents the elimination of bacteria
from the lung permitting bacterial infections to become estab-
lished. Bacterial infections eventually lead to chronic inflamma-
tion, which accounts for the progressive tissue damage and
ultimately to respiratory failure in CF [4]. Indeed CF lung
inflammation is characterized by a sustained accumulation of
neutrophils, high proteolitic activity and elevated levels of pro-
inflammatory cytokines and chemokines [5]. Besides alteration of
the mucociliary clearance system, CFTR mutations might affect
other functions of bronchial epithelial cells including the
internalization of P. aeruginosa, the release of inflammatory
mediators, sphingolipid metabolism and transport of the redox
buffer molecule GSH [6–9].
Recently, several reports suggest that CFTR might be of pivotal
importance in the normal function of immune cells, such
macrophages and neutrophils. For instance, Painter at al. have
shown that CFTR expressed on phagolysosomes is crucial for the
chlorination reactions involved in bacterial killing by human
neutrophils [10,11]. Studies in the CF knockout mice demonstrat-
ed that CFTR participates in phagosomal pH control of murine
alveolar macrophages, thereby CFTR-deficient macrophages
failed to acidify lysosomes and phagolysosomal compartments
and displayed an altered bactericidal activity [12,13]. Additionally,
defects in the ROS mediated killing of P. aeruginosa by murine
CFTR-deficient alveolar macrophages have been recently report-
ed by Zhang et al [14]. This defect has been associated with the
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19970failure of infected macrophages to activate acid sphimgomyelinase
and to release ceramide, thus preventing the formation of
ceramide enriched membrane platforms that serve to cluster and
activate NADPH oxidase [14].
Finally, a contribution of CFTR in the production of different
cytokines by macrophages has been recently described. Bruscia
et al. showed that in response to P. aeruginosa lipopolysaccharide
(LPS), bronchoalveolar fluids from CF mice present significantly
higher concentrations of macrophage derived pro-inflammatory
cytokines such as IL-1a, IL-6, G-CSF and IL-8 as compared to
wild type cells. Results from in vitro stimulation of alveolar and
bone marrow derived macrophages with P. aeruginosa LPS
confirmed the exuberant cytokine production in CF cells [15].
Although these data support the hypothesis that the abnormal
macrophage activity, due to the lack of CFTR might be one of the
causes of persistent bacterial infections and exuberant inflammatory
responses in CF, at present the contribution of CFTRin the physiology
of human macrophages is unknown. In order to define possible
intrinsic macrophage defects due to CFTR deficiencies we have
analyzed the bactericidal activity against P. aeruginosa of human
monocyte derived macrophages from CF patients. To this aim we
have first verified CFTR expression and functional activity in
macrophages from healthy donors, subsequently, we have evaluated
the capacity of CF macrophages to kill intracellular P. aeruginosa.O u r
results show for the first time that, macrophages derived from
peripheral blood monocytes isolated from healthy donors express a
functional CFTR and efficiently kill intracellular bacteria. Comparison
of the bactericidal activity of control and CF macrophages revealed a
significant increase in bacterial survival in cell carrying dysfunctional
CFTR suggesting that CFTR, independently from tissue origin,
directly contributes to microbicidal function of phagocytes.
Materials and Methods
Study subjects
Fifteen patients with CF (Regional Cystic Fibrosis Center,
Sapienza University, Rome Italy), confirmed by positive sweat tests
and genotyping (6 males, 9 females, median age 27) were enrolled in
the study. Clinical and demographic characteristicsof CF patients are
reported in Table 1. Blood samples, for isolation of CD14
+ cells,were
collected when patients attended the clinic for routine evaluation.
Informed written consent was obtained from all participants after
approval of the study by the local ethics committee (Comitato Etico,
Azienda Policlinico Umberto I, Rome, Italy; 21 June 2007). Blood
samples from twelve, sex and age matched healthy donors were used
as controls in bacterial infection assays. Additionally twelve healthy
donor samples were used in RT-PCR experiments.
Isolation and differentiation of human monocytes
Peripheral blood mononuclear cells were isolated by density
gradient centrifugation (Lympholyte, Cedarlane, Hornby, CA).
CD14
+ cells were purified from PBMC by positive selection with
anti-CD14 mAb coupled to magnetic beads (Miltenyi Biotec,
Bergisch Gladbach, Germany). The purity of CD14
+ was routinely
.90% as estimated by flow cytometry using FITC conjugated
CD14 (BD Biosciences). CD14
+ cells were differentiated for 7 days
in RPMI 1640 (Gibco-BRL, Invitrogren Corporation Carlsbad,
CA, USA) supplemented with 20% FCS and 100 ng/ml
recombinant macrophage colony stimulating factor (MCSF;
PeproTech Inch, Rocky Hill, NY, USA).
RNA extraction and real time PCR
Total RNA was isolated from macrophages by Tryzol (Tryzol
Reagent, Invitrogren Corporation Carlsbad, CA, USA) treated
with DNase and purified using the RNeasy mini kit (Qiagen
GmbH, Hilden, Germany) according to the manufacturer’s
instructions. cDNAs were obtained using Reverse Trascription
System kit (Promega, Fitchburg, WI, USA) and random primers.
Real time PCRs were done using SYBR Green PCR Master Mix
(Applied Biosystem, Forster City, CA, USA) according to the
suppliers’ specification. The primers were as follow: for CFTR,
rtCF-F1 59-AAGCGTCATCAAAGCATGCC-39(cDNA nt posi-
tion 1686/1705) and RTCF-R1 (59-TTGCTCGTTGACCTC-
CACTCA-39 (cDNA nt position1775/1795); for the actin gene
(used as the endogenous reference gene) rtbeta-ActF1 59-
GCCGGGACCTGACTGACT-39 and rtbeta-ActR1 59-
TGGTGATGACCTGGCCGT-39. Each sample was amplified
in triplicates and CFTR mRNA level was determined by the DDCt
relative quantification method (7300 System SDS software,
Applied Biosystem). Either parental monocytes or the alveolar
epithelial cell line H441 (ATCC, HTB-174), which expresses low
level of CFTR mRNA, were used as calibrators.
Immunofluorescence and Confocal Laser Scanning
Microscopy (CLSM) analyses
For CLSM analyses, 1610
5 in vitro differentiated macrophages
were seeded in 24-well cluster plates on cover glasses (diameter,
12 mm) the day before analysis. Cells were fixed with parafor-
maldeyde 3% (PFA, 30 min 4uC) permeabilized with 0.5% Triton
X-100 (10 min, room temperature) and then stained at 37uC with
the anti-CFTR polyclonal antibody H-182 (Santa Cruz Biotech-
nology, Santa Cruz California), followed by Alexa Fluor 488-
conjugated goat anti-rabbit IgG F(ab)2 (Molecular Probes,
Eugene, OR). The cover glasses were extensively washed with
PBS 16 and mounted on the microscope slide with Vectashield
antifade mounting medium containing DAPI (Vector Laborato-
ries, Burlingame, CA). To determine CFTR localization in the
lysosomes, macrophages were first stained for CFTR using as
secondary antibody Alexa Fluor-594 goat anti-rabbit IgG F(ab)2,
and then they were labelled with the mouse anti human LAMP-1
Table 1. Characteristics of CF patients.
Patient Age Sex Genotype Microbiology
a FEV1%
CF1 25 M F508del/- none 98%
CF2 34 F F508del/F508del S.a. 76%
CF3 16 F F508del/F508del none 87%
CF4 20 F F508del/F508del S.a. 49%
CF5 24 F F508del/R1162X S.a,P.a. 63%
CF6 34 F F508del/L732X C.a., S.a.,P.a. 33%
CF7 15 M F508del/F508del A.t., S.m. 39%
CF8 22 M F508del/N1303K S.a., P.a. 39%
CF9 23 M F508del/F508del P.a. 91%
CF10 33 F F508del/F508del P.a.,P.f. 49%
CF11 27 F F508del/F508del P.a. 28%
CF12 45 F F508del/F508del P.a. 44%
CF13 30 M W1282X/W1282X P.a. 43%
CF14 28 M F508del/F508del S.a. 66%
CF15 36 F F508del/F508del S.a. 76%
aS.a.: Staphylococcus aureus; P.a.: Pseudomonas aeruginosa; C.a.: Candida
albicans; A.t.: Aspergillus terreus; S.m.: Stenotrophomonas maltophilia; P.f.:
Pseudomonas fluorescens; - unknown;
doi:10.1371/journal.pone.0019970.t001
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IOWA, IOWA City, IA) and the Alexa Fluor-488 F(ab)2 goat anti-
mouse IgG. CLSM observations were performed with a Leica
TCS SP2AOBS apparatus using excitation spectral laser lines 405,
488 and 594 nm and using a 636 oil immersion lens. Image
acquisition and processing were achieved using the Leica Confocal
Software (LCS) (Leica Lasertechnik, Heidelberg, Germany) and
Adobe Photoshop software programs (Adobe system, Mountain
View, CA). Signals from different fluorescent probes were taken in
sequential scan settings, and co-localization was detected in yellow
(pseudo-colour). At least 50 individual cells were analyzed for each
staining condition. Isotype control antibodies were used in all
confocal microscopy experiments to confirm the specificity of
antibody staining.
Electrophysiology recordings
All experiments were conducted at room temperature (22–
24uC) using an Axopatch 200B patch clamp amplifier (Axon
Instruments, Burlingame, CA, USA) and using the pCLAMP 9.0
and CLAMPFIT 9.0 as acquisition and data analyses programs
respectively (Axon Instruments, Burlingame, CA, USA). Patch-
clamp pipettes, obtained using borosilicate glass (Science Products
GmbH, Hofheim, Germany), and a Heka puller (model PIP5,
HEKA Elektronik, Lambrecht/Pfalz Germany), had resistances
between 8–10 MOhms. Whole-cell recordings were performed
according to the method previously described by Hamill et al.
[16]. In vitro differentiated macrophage cells were plated on
35 mm Petri dishes at density of 1610
5 cells/dish, and, during the
current recordings, bathed utilizing solutions in which Cl
2 was the
only possible permeable ion according to the protocol previously
described for epithelial cells [17]. The pipette solution contained
(in mM): 140 N-methyl D-glucamine; 40 HCl; 100 L-glutamic
acid; 0.2 CaCl2; 2 MgCl2; 1 EGTA; 10 HEPES; and 2 ATP-Mg,
pH 7.2. The bath solution contained (in mM): 140 N-methyl D-
glucamine; 140 HCl; 2 CaCl2; 1 MgCl2; and 10 HEPES, pH 7.4.
Cells were stimulated by the addition of a cAMP-activating
cocktail (400 mM cAMP, 10 mM forskolin, 1 mM IBMX) to the
pipette solution with voltage steps ranging from 2110 to +110 mV
for 200 ms with increments of 10 mV from a holding potential of
240 mV.
Bactericidal assay
This assay was performed as described by Auriche C. et al. with
minor modifications [18]. Briefly, the day before infection,
macrophages were seeded in 48 well plates (1610
5 cells/well). P.
aeruginosa, strain ATCC 27853, was grown over night in tryptic soy
medium, harvested by centrifugation, washed twice in PBS 16
and once in serum-free RPMI 1640 medium before being re-
suspended in RPMI 1640 supplemented with 10% FBS at
,10
7 CFU/ml. Based on preliminary experiments and previously
published data macrophages were infected at a multiplicity of
infection (MOI) of 30, i.e. 30 bacteria for one macrophage [12,18].
Bacteria were brought in contact with macrophages by centrifu-
gation (500 g for 10 min). The end of centrifugation was
considered the starting point of infection which proceeded for
1h ra t3 7 uCi n5 %C O 2. After infection, the cells were gently
washed with PBS 16 (three times) and incubated for 1 hr in
culture medium containing gentamycin (400 mg/ml each) to kill
the extracellular bacteria. The end of this step was codified as t0.
Some wells were lysed to determine the number of intracellular
bacteria at t0; others were incubated in antibiotic-free medium for
additional four hours; samples were taken after 2 (t2) and 4 (t4)
hours from t0.
Intracellular bacteria were counted by lysing the cells with 1%
Triton X-100 in PBS 16and plating serial dilutions of the lysates
on PIA plates (Pseudomonas Isolation Agar). The fraction of
internalized bacteria was determined with respect to the CFU used
to infect the cells (the input), whereas bacterial survival was
determined with respect to the CFU recovered at t0.
Each experimental section included the following controls: wells
of uninfected macrophages; wells inoculated with bacteria only.
Data were considered only when the following conditions were
confirmed: lysates from un-infected macrophages did not revealed
any bacterial colony on PIA plates; bacteria alone incubated for
1 hr with 400 mg/ml gentamycin were completely killed (,10
CFU left). Viability of macrophages after infection was determined
by trypan blue counting in representative experiments and
Annexin V staining.
Statistical analysis
Mann-Whitney nonparametric test was used to investigate the
significance of differences on bacteria counts between cases and
controls at the different time-points analyzed. The same test was
performed to evaluate differences on bacteria survival between
cases and controls (at t2 and t4). P values less than 0.05 were
considered statistically significant.
All the statistical procedures were performed by STATA 11
statistical package.
Results
CFTR expression in macrophages and precursor cells
As first, we wanted to assess whether the CFTR was expressed
by in vitro differentiated macrophages and parental monocytes. For
this purpose total RNA was extracted from both cell populations
obtained by twelve healthy donors and CFTR mRNA was
detected by real time PCR. The resulting data were analyzed by
the relative quantification method using as calibrators either the
low expressing control cells H441 or the parental monocytes
(Fig. 1A and 1B). Both monocytes and macrophages showed
CFTR expression, however the level of the CFTR transcript was
higher in macrophages with respect to parental monocytes.
Indeed, in most of the macrophage populations analyzed (8/12)
we detected 2–15 fold increase of the CFTR mRNA in
macrophages with respect to parental monocytes, in one sample
we didn’t observe significant variation and in 3 samples we
observed a reduction down to half of that observed in monocytes
(Fig. 1B). Overall these data demonstrate that in vitro differentiated
macrophages express CFTR.
Expression and functional activity of CFTR protein in
differentiated macrophages
Having demonstrated the presence of CFTR mRNA in
monocyte derived macrophages, we analyzed the expression of
CFTR protein by immunofluorescence using the anti-CFTR
antibody H-182 (Santa Cruz), raised against the first 182 aa of the
protein. Examination of in vitro differentiated macrophages from
control individuals by confocal microscopy showed that the
majority of cells expressed CFTR which mainly localized at the
plasma membranes or in their vicinity (Fig. 2A and 2B).
Additionally, detectable intracellular staining was observed in a
small percentage of the cells (Fig. 2A). By contrast, in CF
macrophages homozygous for F508del mutation, the global
immunofluorescence signal was much lower with respect to wild
type (wt) cells and the brightest CFTR staining was found in the
cytoplasm indicating a predominant intracellular localization of
the protein (Fig. 2A).
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lysosomal vescicles of MDM, we double stained control MDM for
CFTR and for the lysosomal-associated membrane protein 1
(LAMP1). Results from this analysis confirmed the plasma
membrane localization of CFTR but they did not allow to
demonstrate any co-localization of CFTR with the lysosomal
marker as previously reported in murine lung macrophages
(Fig. 2B).
To test if the antibody revealed protein was also functional,
whole cell patch-clamp analyses were performed utilizing solutions
in which chloride was the only mobile ion. This experimental
protocol allowed to record currents from the entire CFTR channel
population expressed on the plasma membrane of macrophages
(basal; panel A Fig. 3). The presence of cAMP-containing cocktail,
after 2–4 min of the establishment of the whole cell patch clamp
configuration, stimulated a twofold increase in Cl
2 currents with
respect to the basal condition (cAMP, panel A Fig. 3). The
treatment with the thiazolidinone CFTRinh-172, a selective blocker
of the cystic fibrosis transmembrane conductance regulator,
reverted the cAMP-evoked Cl
2 currents (cAMP/CFTRinh-172,
panel A Fig. 3). The graph in panel B of figure 3 shows the
current/voltage relationship indicating that the currents appeared
voltage independent with a chloride-selective reversal potential.
The current density observed under basal conditions was
3,5460,45 pA/pF, this value increased up to 6,6760,88 pA/pF
in cAMP-induced activation conditions, while in presence of
CFTRinh-172 the obtained current density was 3,1560,96 pA/pF,
a value similar to that observed in basal conditions (panel C,
Fig. 3).
Bactericidal activity in wt and CF macrophages
Our data clearly demonstrate that CFTR is expressed and it is
functionally active as a Cl
2 channel in monocyte-derived
macrophages isolated from healthy donors. Next, we determined
the bactericidal activity of monocyte-derived macrophages from
healthy donors (non-CF) and CF individuals against P. aeruginosa.A
descriptive panel of the patients tested for macrophage bactericidal
activity is reported in Table 1, in addition healthy donors matched
for sex and age were included as controls. Overall the bactericidal
activity was assayed in 15 CF samples and 12 non-CF controls.
The bactericidal activity of macrophages was assayed using the
antibiotic protection method over a 4 hr time period. After
infection, intracellular live bacteria were detected by the colony-
forming unit (CFU) method at three time points: at the end of
infection; two and four hours after infection. In order to ensure
identical experimental conditions at least one non-CF and one CF
sample were evaluated in each experimental section. The first data
we have analysed was the number of intracellular live bacteria at
the end of infection, which could be influenced by the phagocytic
capacity of macrophages. The median number of live bacteria
recovered from infected macrophages were 2108 and 1506 in HD
and CF macrophages respectively with no significant differences
between the two groups (P=0,9611) suggesting that the phago-
cytic activity of these cells was very similar.
Next we determined the percentage of live bacteria two and
four hours after infection with respect to the bacteria recovered at
the end of infection. Two hours after infection, non-CF
macrophages caused a rapid decline in the fraction of intracellular
live bacteria down to a median percentage of survival of 26,4.
Similarly, but to a lesser extent, CF macrophages reduced the
percentage of intracellular live bacteria down to 33,34 (Fig. 4).
Statistical evaluation of these results failed to reveal significant
differences between the two groups at this time point. Only two
macrophage samples were found to diverge from the majority: one
non-CF sample showed an increase in the number of live bacteria
two hours after infection of about two order of magnitude with
respect to the other HD samples; similarly, at the same time point
post-infection, one CF showed an increased number of live
bacteria but by a factor of 10 (Fig. 4 and Fig. 5). However, both
samples showed a subsequent reduction of intracellular live
bacteria. Of note these samples have been analyzed in different
experimental sections together with samples that behaved as the
majority of macrophages. In the next time point analysed (four
hours after infection) live bacteria recovered from non-CF
macrophages were significantly less than those recovered from
CF macrophages. Indeed the median percentage of live bacteria
recovered from HD and CF macrophages was 16,90 and 25
respectively; (P=0,0359). Although the deficit in the killing activity
of CF versus non-CF macrophages was not as severe as previously
reported for murine alveolar macrophages [12,13] this result
Figure 1. CFTR mRNA expression in human in vitro differentiated macrophages from non-CF donors. Panel A: Mean relative quantitiy
(RQ) of CFTR mRNA in monocytes (CD14
+) and monocyte derived macrophages (MDM) calibrated versus the H441 cells (low control); each symbol
represents a single donor. Panel B: CFTR mRNA in MDM (mean RQ) calibrated versus parental monocytes. Each bar represents a single donor, whiskers
above and below are the RQ-max and RQ-min, respectively.
doi:10.1371/journal.pone.0019970.g001
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deficiency of bactericidal activity. Furthermore, counting of viable
macrophages and evaluation of apoptosis by annexinV staining
(data not shown) failed to reveal differences in cell viability during
the time course of the experiments excluding that the reduction in
surviving bacteria was due to cell death. It has to be pointed out
that the cellular model we have used for this analysis consists of
macrophages which were not conditioned by the lung environ-
ment and thereby represent the best system to highlight possible
intrinsic deficiencies of CF macrophages.
Discussion
Chronic inflammation of the lung, as a consequence of persistent
bacterial infections by several opportunistic pathogens represents
the main cause of mortality and morbidity in CF patients [19]. At
present the causes of the inability of CF patients to eradicate
bacterial infections have beenmainly ascribed to dysfunctions in the
defence mechanisms mediated by airway epithelial cells. More
recently, several studies in the murine model demonstrated that
dysfunctional CFTR might alter the bactericidal activity of alveolar
macrophages, further contributing to the poor control of bacterial
growth in CF patients [12–14,20]. In order to evaluate whether a
similar defect affects human macrophages, we have compared the
capacity of monocyte derived macrophages (MDM) from CF and
control individuals to kill intracellular P. aeruginosa. The choice of
this model was dictated by our primary goal i.e. analysis of possible
intrinsic defects of macrophages which requires macrophagic cells
unconditioned by the lung environment.
Due to the lack of available data, first we verified the expression
and activity of CFTR in human macrophages by different
techniques; i.e. RT-PCR, immunofluorescence, patch clamp
recording. Our immunofluorescence localization data on MDM
from healthy individuals demonstrated that wild type CFTR is
predominantly localized at the plasma membranes or in the
vicinity of them in the majority of MDM, with a small percentage
of cells showing an intracellular localization. In contrast the same
analysis on F508del homozygous cells revealed a strong reduction
of plasma membrane staining compared to that observed in the
cytoplasm. This latter finding might be explained by the
elimination of misfolded CFTR by cellular quality control
mechanisms. Indeed deletion of the F508 residue, which
represents the most prevalent mutation in the CFTR, causes a
temperature sensitive folding defect leading to protein degradation
by the endoplasmic reticulum associated degradation machinery
[21]. In addition our data are in agreement with previous reports
showing that F508del CFTR protein mislocalizes from the apical
membranes to the cytoplasm in primary airway and nasal
epithelial cells [22,23].
Consistently with plasma membrane localization of CFTR,
whole-cell patch-clamp recordings from MDM from healthy
individuals showed that the presence of Cl
2 currents increased in
the presence of an intracellular cAMP stimulation. As expected, the
currents recorded were sensitive to CFTRinh-172, which has been
reported to specifically block CFTR Cl
2 conductance, supporting
the results that the CFTR channels, not only are localized at plasma
membrane, but are also functional [24]. Peak current density
measured from human MDM during cAMP activation revealed
lower values than those recorded by Di and collaborators from
human alveolar macrophages [12]. This difference could be due to
a different functional status of the analysed cell population; in
addition, alsodifferent levels ofCFTR onplasmamembrane, dueto
different tissue origins, could be postulated.
It has been previously reported that CFTR is present not only at
the plasma membranes but also within phagosomes, lysosomes and
possibly other intracellular compartments in murine lung
macrophages [12,14]. Our results from double staining of
permeabilized MDM with anti-CFTR and the anti-lysosomal
marker LAMP1 did not support the expression of CFTR in
lysosomes of human MDM. Differences between our data and
those reported by Zhang and collaborators showing that CFTR
localizes with some LAMP1 positive vesicles in freshly isolated
lung macrophages might be explained either by differences in the
cellular localization of CFTR in distinct species or in cells from
different anatomical sites (periphery vs lung), or both. However, we
cannot exclude that CFTR localization in lysosomal vesicles
couldn’t be detected by immunofluorescence due to low sensitivity
of the method, indeed in the J774 murine macrophage cell line,
immunoelectron microscopy was employed to co-localize CFTR
and LAMP1 [12].
The role of CFTR in regulating bactericidal activity by
macrophages was first demonstrated in 2006 in murine macro-
phages, this defect was observed in lung, but not peritoneal,
macrophages and was related to the inability of CFTR2/2
macrophages to maintain an acidic pH in the intralysosomal
Figure 2. Confocal microscopy of the cellular localization of
CFTR in control and F508del human in vitro differentiated
macrophages. (A) Localization of CFTR in macrophages from non-CF
(top row) and del508F homozygous CF individuals (bottom row).
Permeabilized macrophages were stained with the polyclonal anti-CFTR
antibody (H-182) and with Alexa Fluor 488-conjugated secondary
antibody. Nuclei were counterstained with DAPI. Scale bars=20 micron.
Isotype negative controls are shown in the insets. (B) Permeabilized
macrophages were stained with the anti-CFTR and the anti-LAMP1
antibodies; the secondary antibodies were Alexa Fluor-594 and Alexa
Fluor-488 conjugated F(ab)2 IgG. Scale bar=10 micron.
doi:10.1371/journal.pone.0019970.g002
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same group, produced contrasting results and the involvement of
CFTR in lysosomal acidification is still debated [13,25–28]. More
recently measurements of ROS release, following P. aeruginosa
infection, by WT and CFTR-deficient murine alveolar macro-
phages revealed a deficiency in ROS production and P. aeruginosa
killing in CF macrophages. It has to be noted that Di and
collaborators failed to reveal differences in ROS production by
alveolar macrophages isolated from WT and CFTR-deficient mice
[12]. Although the different experimental conditions might be
responsible for these contradictions, whether CFTR activity has a
direct role in phagosomal acidification and the mechanism/s
responsible for macrophage dysfunction, are still opened questions.
In this scenario, and due to the very few data on human
macrophages, we have focused our attention on non-conditioned
phagocytic cells, such as MDM, and studied the ability to kill P.
aeruginosa. First, we determined whether differences could be found
in the fraction of internalized bacteria at the end of infection
between WT and CF macrophages. Statistical analysis of our data
failed to reveal any significant difference suggesting that the
phagocytic activity of monocyte derived macrophages is not
affected by CFTR. Next, we determined the outcome of the
intracellular bacteria over a period of 4 hour after infection. In the
first 2 hours after infection, the fraction of live bacteria decreased
at similar extend in WT and CF macrophages. On the contrary
4 hours after infection, although live bacteria continued to
decrease, those recovered from CF macrophages were significantly
more than from control cells. Thereby, for the first time to the best
Figure 3. Whole-cell patch clamp of cAMP-evoked Cl
2 current in human peripheral macrophages. (A) representative currents in basal
condition (basal) or in response to the administration the cAMP-containing cocktail (cAMP), recorded on voltage-clamped macrophages. cAMP-
evoked currents were blocked in the presence of the specific inhibitor CFTRinh-172 (10 mM), added to the bath solution (cAMP/CFTRinh-172). Currents
were recorded in 200 ms voltage steps from 2110 to +110 mV with 10 mV increments from a holding potential of 240 mV. (B) Averaged current/
voltage relationship in basal conditions (basal, n=9), in the presence of a cAMP-containing cocktail (cAMP, n=16) or cAMP-containing cocktail plus
10 mM CFTRinh-172 (cAMP/CFTRinh-172, n=7). (C) Current densities obtained at +110 mV in the three described experimental conditions, in parentheses
the number of recorded cells are shown. Data reported in panel (B) and (C) are means6S.E.
doi:10.1371/journal.pone.0019970.g003
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PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19970of our knowledge, we show that the bactericidal activity of human
macrophages is indeed affected by CFTR-deficiency. Defective
clearance of apoptotic cells has been previously reported in human
MDM when exposed to the aqueous sol fraction of sputum
recovered from CF patients. This impairment has been associated
with the cleavage of phosphatidylserine receptor in a neutrophil
elastase dependent manner [29]. Our data highlights a novel
dysfunction of human CF MDM which, since it cannot be
ascribed to conditioning by CF lung environment, reflects a
primary defect of CF MDM. It is interesting to note that the
observed defect in the bactericidal activity of human CF MDM
was less profound than that previously demonstrated in murine CF
alveolar macrophages. A possible explanation for this finding is the
existence of multiple bactericidal mechanisms employed by human
MDM to kill P. aeruginosa whose, only a part might be affected by
CFTR deficiency as previously reported for human neutrophils
[11]. Two strong clinical correlations have been identified in CF: i)
a positive correlation between persistent P. aeruginosa infection and
worst prognosis for the patients ii) a marked adaptation of the
bacteria to the CF lung by a number of changes including loss of
bacteria motility, altered antibiotic susceptibilities and metabolic
shift (decreased oxygen consumption and increased nitrate
utilization) [30–33]. Since our data were obtained with a P.
aeruginosa strain, that might not recapitulate the phenotypes of
chronic isolates it is reasonable to surmise that the observed deficit
of bactericidal activity of CF macrophages could be more
pronounced when challenged with late clinical isolates. It is
generally accepted that phagocytic cells use a combination of
oxidative and non-oxidative mechanisms to defend against a great
variety of engulfed microorganisms [34]. Having demonstrated
that the microbicidal activity of CF macrophages is significantly
reduced four hours after infection but not at the previous time
point (two hours), it might be hypothesised that multiple
bactericidal mechanisms operating with different kinetics are
differently affected by CFTR activity. Experiments are underway
to analyse the molecular pathways leading to bacteria killing in
WT and CF MDM.
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